Product Information
NEOMYCIN-POLYMYXIN-HC EAR SOLN is a generic product labeled by Sandoz Inc., priced at $4.0565 per ML under NDC 61314064610. Its NADAC has been published 575 times since Nov 28, 2013.
FDA first approved this application on Aug 25, 1983. Its Orange Book therapeutic-equivalence code is AT.
Strength
10; 3.5; 10000 mg/mL; mg/mL; [iU]/mL
Manufacturer
Sandoz Inc.NDC
61314064610
Classification
Generic
Dosage Form
SOLUTION
Route
AURICULAR (OTIC)
Effective Date
11/20/2024
Active Ingredients
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062423FDA Approved
8/25/1983
TE Code
AT
On Market Since
3/18/2003
Pharmacological Classes
Price Statistics
The NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has been published 575 times since Nov 28, 2013, and over the history we have for it it has risen 115.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0565 per ML |
|---|---|
| All-time high | $6.5838 (Oct 13, 2021) |
| All-time low | $1.7627 (Sep 23, 2015) |
| Median price | $5.3611 |
| Average price | $4.8390 |
| Largest weekly change | +200.5% (Oct 21, 2015) |
| Weeks tracked | 575 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.0%
5Y
-35.8%
All
+115.2%
Last surveyed Nov 27, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the neomycin sulfate, polymyxin b sulfate and hydrocortisone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEOMYCIN-POLYMYXIN-HC EAR SOLN?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYCIN-POLYMYXIN-HC EAR SOLN, manufactured by Sandoz Inc., is $4.0565 per ML (NDC 61314064610), effective Nov 27, 2024.
How has the price of NEOMYCIN-POLYMYXIN-HC EAR SOLN changed over time?
Over the history we have for it, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has risen 115.2%. It has been tracked across 575 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYCIN-POLYMYXIN-HC EAR SOLN?
Since Nov 28, 2013, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has ranged from a low of $1.7627 (Sep 23, 2015) to a high of $6.5838 (Oct 13, 2021), with a median of $5.3611 per ML.
Are there cheaper alternatives to NEOMYCIN-POLYMYXIN-HC EAR SOLN?
No other NADAC-published product currently shares the active ingredient and strength of NEOMYCIN-POLYMYXIN-HC EAR SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEOMYCIN-POLYMYXIN-HC EAR SOLN?
NEOMYCIN-POLYMYXIN-HC EAR SOLN (NDC 61314064610) is labeled by Sandoz Inc., and CMS classifies it as a generic product.